HUP0100999A2 - Citosztatikus szerek - Google Patents
Citosztatikus szerek Download PDFInfo
- Publication number
- HUP0100999A2 HUP0100999A2 HU0100999A HUP0100999A HUP0100999A2 HU P0100999 A2 HUP0100999 A2 HU P0100999A2 HU 0100999 A HU0100999 A HU 0100999A HU P0100999 A HUP0100999 A HU P0100999A HU P0100999 A2 HUP0100999 A2 HU P0100999A2
- Authority
- HU
- Hungary
- Prior art keywords
- isobutylhex
- enoylamino
- hydroxycarbamoyl
- proliferation
- cyclopentyl ester
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB1998/000754 WO1999046241A1 (en) | 1998-03-12 | 1998-03-12 | Cytostatic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0100999A2 true HUP0100999A2 (hu) | 2001-08-28 |
Family
ID=10825272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0100999A HUP0100999A2 (hu) | 1998-03-12 | 1998-03-12 | Citosztatikus szerek |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1062202B1 (enExample) |
| JP (1) | JP4324324B2 (enExample) |
| KR (1) | KR20010041661A (enExample) |
| CN (1) | CN1141292C (enExample) |
| AT (1) | ATE231122T1 (enExample) |
| AU (1) | AU747977B2 (enExample) |
| BR (1) | BR9815717A (enExample) |
| CA (1) | CA2323414C (enExample) |
| CZ (1) | CZ299610B6 (enExample) |
| DE (1) | DE69810817T2 (enExample) |
| GB (1) | GB2349149A (enExample) |
| HU (1) | HUP0100999A2 (enExample) |
| IL (2) | IL137774A0 (enExample) |
| NO (1) | NO20004528D0 (enExample) |
| NZ (1) | NZ506293A (enExample) |
| PL (1) | PL190637B1 (enExample) |
| WO (1) | WO1999046241A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9901863D0 (en) * | 1999-01-29 | 1999-03-17 | British Biotech Pharm | Antibacterial agents |
| WO2019039937A1 (en) | 2017-08-21 | 2019-02-28 | Stichting Vumc | POLYTHERAPY FOR THE TREATMENT OF CANCER |
| US10925851B2 (en) | 2018-03-15 | 2021-02-23 | Regents Of The University Of Minnesota | Use of Tosedostat and related compounds as analgesics |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0639982A1 (en) * | 1992-05-01 | 1995-03-01 | British Biotech Pharmaceuticals Limited | Use of mmp inhibitors |
| GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
| US5691381A (en) * | 1995-04-18 | 1997-11-25 | The Dupont Merck Pharmaceutical Company | Hydroxamic and carbocyclic acids as metalloprotease inhibitors |
| NZ333923A (en) * | 1996-09-10 | 2000-11-24 | British Biotech Pharm | Cytostatic hydroxamic acid derivatives for inhibiting proliferation of tumour cells |
-
1998
- 1998-03-12 AU AU64106/98A patent/AU747977B2/en not_active Expired
- 1998-03-12 EP EP98909620A patent/EP1062202B1/en not_active Expired - Lifetime
- 1998-03-12 DE DE69810817T patent/DE69810817T2/de not_active Expired - Lifetime
- 1998-03-12 PL PL98342811A patent/PL190637B1/pl unknown
- 1998-03-12 CZ CZ20003317A patent/CZ299610B6/cs not_active IP Right Cessation
- 1998-03-12 IL IL13777498A patent/IL137774A0/xx active IP Right Grant
- 1998-03-12 BR BR9815717-5A patent/BR9815717A/pt unknown
- 1998-03-12 AT AT98909620T patent/ATE231122T1/de not_active IP Right Cessation
- 1998-03-12 GB GB0019414A patent/GB2349149A/en not_active Withdrawn
- 1998-03-12 HU HU0100999A patent/HUP0100999A2/hu unknown
- 1998-03-12 CN CNB988138476A patent/CN1141292C/zh not_active Expired - Lifetime
- 1998-03-12 JP JP2000535622A patent/JP4324324B2/ja not_active Expired - Lifetime
- 1998-03-12 CA CA002323414A patent/CA2323414C/en not_active Expired - Lifetime
- 1998-03-12 NZ NZ506293A patent/NZ506293A/en not_active IP Right Cessation
- 1998-03-12 WO PCT/GB1998/000754 patent/WO1999046241A1/en not_active Ceased
- 1998-03-12 KR KR1020007009865A patent/KR20010041661A/ko not_active Withdrawn
-
2000
- 2000-08-09 IL IL137774A patent/IL137774A/en not_active IP Right Cessation
- 2000-09-11 NO NO20004528A patent/NO20004528D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ506293A (en) | 2003-05-30 |
| EP1062202B1 (en) | 2003-01-15 |
| CZ20003317A3 (cs) | 2001-03-14 |
| NO20004528L (no) | 2000-09-11 |
| CA2323414C (en) | 2008-05-13 |
| PL190637B1 (pl) | 2005-12-30 |
| CZ299610B6 (cs) | 2008-09-17 |
| KR20010041661A (ko) | 2001-05-25 |
| GB2349149A (en) | 2000-10-25 |
| CN1141292C (zh) | 2004-03-10 |
| AU747977B2 (en) | 2002-05-30 |
| AU6410698A (en) | 1999-09-27 |
| WO1999046241A1 (en) | 1999-09-16 |
| CA2323414A1 (en) | 1999-09-16 |
| PL342811A1 (en) | 2001-07-02 |
| DE69810817T2 (de) | 2003-11-20 |
| JP2002506057A (ja) | 2002-02-26 |
| GB0019414D0 (en) | 2000-09-27 |
| IL137774A0 (en) | 2001-10-31 |
| BR9815717A (pt) | 2000-11-07 |
| CN1286681A (zh) | 2001-03-07 |
| NO20004528D0 (no) | 2000-09-11 |
| JP4324324B2 (ja) | 2009-09-02 |
| DE69810817D1 (de) | 2003-02-20 |
| ATE231122T1 (de) | 2003-02-15 |
| EP1062202A1 (en) | 2000-12-27 |
| IL137774A (en) | 2006-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2833493A1 (en) | Amide compound and pharmaceutical application therefor | |
| US20070010457A1 (en) | Caspase inhibitors and uses thereof | |
| JPH08508027A (ja) | 金属タンパク加水分解酵素阻害剤である天然アミノ酸誘導体 | |
| SK282529B6 (sk) | Merkaptoalkanoylový a acylmerkaptoalkanoylový derivát oxazepínu, tiazínu a tiazepínu, spôsob jeho výroby, medziprodukt na jeho výrobu a farmaceutický prípravok, ktorý ho obsahuje | |
| KR20070046849A (ko) | 신규한 티오펜 유도체 | |
| JP7743082B2 (ja) | Ｔｙｋ２活性を阻害する複素環式化合物 | |
| US9605021B2 (en) | Indoline compounds as granzyme B inhibitors | |
| US9969772B2 (en) | Covalent granzyme B inhibitors | |
| US20250250253A1 (en) | Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamide | |
| CA3184979A1 (en) | Immunomodulator | |
| US5750687A (en) | Azepinone compounds useful in the inhibition of ACE and NEP | |
| US20200062803A1 (en) | Azaindoline compounds as granzyme b inhibitors | |
| HUP0100999A2 (hu) | Citosztatikus szerek | |
| KR101264934B1 (ko) | 아미도메틸-치환1-(카르복시알킬)-시클로펜틸카보닐아미노-벤자제핀-ｎ-아세트산 유도체, 그것의 제조를 위한 공정 및 중간체 생성물및 이들 화합물을 포함하는 의약품 | |
| RU2187499C2 (ru) | Цитостатические агенты | |
| AU2021355480A9 (en) | Imidazopiperazine inhibitors of transcription activating proteins | |
| MXPA00008762A (en) | Cytostatic agents | |
| JPH09188631A (ja) | Ｆａｓリガンド可溶化抑制薬 | |
| CZ20003721A3 (cs) | Způsob léčby parazitárních chorob inhibici » cysteinových proteas z nadčeledi papainu |